Weight-loss medicines
The approved weight-loss medicines side by side: how much weight people actually lost in the trials, what they cost your stomach, and what happens when you stop. Spoiler: the newer injections lead, and none of them is a course you finish.
At a glance
- For
- Adults with obesity (BMI 30 or more), or BMI 27 or more with a weight-related condition, alongside diet and activity
- Works
- Average loss in the main trials: tirzepatide 15–21%, semaglutide about 15%, phentermine/topiramate about 9% more than dummy treatment, liraglutide 8%, naltrexone/bupropion about 6%, orlistat a few kilograms. Dummy treatment: about 1–3%
- Cost
- None are on the PBS for weight loss (October 2026). Wegovy is being reconsidered for some people with heart disease and obesity
- Kicks in
- Appetite changes within weeks; most weight loss over 6–18 months
- Taken for
- Long term for most. Phentermine is approved only for short courses (up to 3 months)
- Watch for
- Nausea and gut upsets (injections), racing heart and poor sleep (phentermine), oily leakage (orlistat)
If it’s sold with a before-and-after photo and a countdown timer, it isn’t on this list for a reason.
Brand names
- Tirzepatide: Mounjaro
- Semaglutide 2.4 mg: Wegovy
- Liraglutide 3 mg: generic liraglutide (the Saxenda brand left Australia in December 2025)
- Phentermine: Duromine
- Naltrexone with bupropion: Contrave
- Orlistat: Xenical (pharmacist only, no script needed)
- Phentermine with topiramate: Qsymia (US); not approved as a combination in Australia
How it works
- Gut-hormone copies (tirzepatide, semaglutide, liraglutide): slow the stomach and turn up fullness signals in the brain. See GLP-1 medicines.
- Phentermine: a stimulant that suppresses appetite.
- Naltrexone/bupropion: acts on the brain’s appetite and reward pathways.
- Orlistat: blocks about a third of the fat you eat from being absorbed.
Used for
- Weight management alongside a lower-calorie diet and more activity
- Extra approved uses for some: type 2 diabetes, lowering heart risk (Wegovy), sleep apnoea with obesity (Mounjaro)
Compared
Weight figures are average loss in the main trial, on the medicine versus a dummy treatment. Both groups had diet and activity advice, so the medicine’s effect is on top of lifestyle changes.
- Weekly injectionTirzepatide (Mounjaro)
- How it works
- Copies two gut hormones (GIP and GLP-1)
- How taken
- Weekly injection, dose stepped up every 4 weeks
- Weight loss
- SURMOUNT-1: 15.0–20.9% (by dose) vs 3.1% over 72 weeks
- Common side effects
- Nausea, diarrhoea, vomiting, constipation, less appetite
- Not for
- Pregnancy; medullary thyroid cancer or MEN2. Can make the pill less reliable
- When stopped
- SURMOUNT-4: people switched to dummy injections regained 14% of their weight over the next year; those who continued lost another 5.5%
- Weekly injectionSemaglutide 2.4 mg (Wegovy)
- How it works
- Copies a gut hormone (GLP-1)
- How taken
- Weekly injection, dose stepped up every 4 weeks
- Weight loss
- STEP 1: 14.9% vs 2.4% over 68 weeks
- Common side effects
- Nausea, diarrhoea, vomiting, constipation, gallstones
- Not for
- Pregnancy; medullary thyroid cancer or MEN2
- When stopped
- STEP 1 extension: about two-thirds of the lost weight came back within a year
- Daily injectionLiraglutide 3 mg (generics)
- How it works
- Copies a gut hormone (GLP-1)
- How taken
- Daily injection
- Weight loss
- SCALE: 8.0% vs 2.6% over 56 weeks
- Common side effects
- Nausea, diarrhoea, constipation, vomiting
- Not for
- Pregnancy; medullary thyroid cancer or MEN2
- When stopped
- Weight tends to return, as with the weekly versions
- Daily capsulePhentermine (Duromine)
- How it works
- Stimulant appetite suppressant
- How taken
- One capsule in the morning (not at night: it keeps you awake)
- Weight loss
- Approved only for short courses, so long-term trial data are thin
- Common side effects
- Racing heart, raised blood pressure, poor sleep, restlessness, dry mouth
- Not for
- Heart or blood vessel disease, moderate to severe high blood pressure, overactive thyroid, glaucoma, past drug or alcohol misuse, agitation or some mental health conditions
- When stopped
- Courses are limited to 3 months, then reviewed
- Not approved in AustraliaPhentermine with topiramate (Qsymia)
- How it works
- Stimulant plus an anti-seizure medicine that also reduces appetite
- How taken
- Daily capsule (US). In Australia, sometimes as two separate off-label scripts
- Weight loss
- EQUIP and CONQUER: about 9% more than dummy treatment over 56 weeks at the top dose
- Common side effects
- Tingling, dry mouth, constipation, taste change, mood or concentration problems
- Not for
- Pregnancy (topiramate causes birth defects, so reliable contraception is essential), glaucoma, overactive thyroid, heart disease
- When stopped
- Weight tends to return
- TabletsNaltrexone with bupropion (Contrave)
- How it works
- Acts on the brain’s appetite and reward pathways
- How taken
- Tablets, built up over 4 weeks to 2 tablets twice a day
- Weight loss
- COR-I: about 6.1 kg vs 1.4 kg (roughly 6% vs 1%) over 56 weeks
- Common side effects
- Nausea, constipation, vomiting, headache, dizziness, dry mouth
- Not for
- Seizures, anyone taking opioids (it blocks them), uncontrolled blood pressure, eating disorders, bipolar disorder, pregnancy
- When stopped
- Stopped at 16 weeks if less than 5% of body weight has been lost
- Capsule with mealsOrlistat (Xenical)
- How it works
- Blocks about a third of dietary fat from being absorbed
- How taken
- Capsule with each main meal that contains fat
- Weight loss
- XENDOS: 5.8 kg vs 3.0 kg over 4 years, with 37% fewer new cases of diabetes
- Common side effects
- Oily spotting, wind with discharge, urgent or fatty stools, worse after fatty meals
- Not for
- Long-term gut absorption problems, bile flow problems, pregnancy
- When stopped
- Effects stop when the capsules do
Coming soon (not approved in Australia)
- Not approved in AustraliaSemaglutide 25 mg tablet (Wegovy pill)
- Status
- Approved in the US in December 2025
- Weight loss
- OASIS 4: 16.6% vs 2.7% over 64 weeks, in people who kept taking it
- Not approved in AustraliaOrforglipron (Foundayo)
- Status
- Daily pill, no food or water timing rules. Approved in the US in April 2026; submitted to the TGA
- Weight loss
- ATTAIN-1: up to 11.2% vs 2.1% over 72 weeks
- Not approved anywhereCagriSema (cagrilintide with semaglutide)
- Status
- Weekly injection. US decision expected late 2026
- Weight loss
- REDEFINE 1: 20.4% vs 3.0% over 68 weeks
- Not approved anywhereRetatrutide
- Status
- Weekly injection acting on three hormones. Still in trials
- Weight loss
- TRIUMPH-1: 19.0–28.3% (by dose) over 80 weeks
Save your money
- Weight-loss supplements (garcinia, green tea extract, raspberry ketone, chitosan, glucomannan): little or no effect in good-quality trials. Garcinia and green tea extract have been linked to liver damage.
- HCG injections or drops: no evidence they work and not approved for weight loss. Any loss comes from the 500-calorie diet sold with them.
- Compounded or online “Ozempic”: banned from compounding in Australia since October 2024, and often fake or the wrong dose.
- Lifestyle still matters. Every trial above added medicine on top of diet and activity changes. Protein, strength exercise and sleep help keep muscle and keep weight off.
Side effects
- Injections (tirzepatide, semaglutide, liraglutide): nausea, vomiting, diarrhoea, constipation, reflux, gallstones; rarely pancreatitis.
- Phentermine: racing heart, raised blood pressure, poor sleep, restlessness, dry mouth; rarely heart valve or lung blood pressure problems.
- Naltrexone/bupropion: nausea, constipation, headache, dizziness; rarely seizures or mood changes.
- Topiramate: tingling, poor concentration, mood changes, kidney stones.
- Orlistat: oily leakage and urgency; take a multivitamin at bedtime.
Get help urgently if
- Severe tummy pain that won’t settle, sometimes going through to the back (possible pancreatitis)
- Pain under the right ribs, fever or yellow skin (possible gallstones)
- Chest pain, a racing or irregular heartbeat, fainting or new breathlessness (especially on phentermine)
- A seizure, or new low mood or thoughts of self-harm. In Australia, Lifeline is on 13 11 14
- Swelling of the face or throat, or trouble breathing
Good to know
- Pregnancy: none are used in pregnancy. Topiramate causes birth defects; tirzepatide can make the pill less reliable.
- Muscle: a good share of weight lost is lean tissue. Enough protein and strength exercise help protect it.
- Surgery: tell your team you take a GLP-1 medicine (slower stomach emptying) or naltrexone (blocks opioid pain relief).
- Use only TGA-approved products from a pharmacy.
Common questions
Which weight-loss medicine works best?
On average, tirzepatide, then semaglutide. In a head-to-head trial, people lost 20.2% of their weight on tirzepatide versus 13.7% on semaglutide over 72 weeks. Results vary a lot from person to person.
Do I have to take weight-loss medicine forever?
For most people, the weight comes back after stopping. In trials, most of the lost weight returned within a year of stopping semaglutide or tirzepatide. They work more like blood pressure medicine than a course of antibiotics.
Are weight-loss injections on the PBS?
Not for weight loss, as of October 2026. Ozempic is PBS-subsidised for type 2 diabetes only. Wegovy is being reconsidered for some people with heart disease and obesity.
Do weight-loss supplements work?
Not in good-quality trials. Garcinia, green tea extract, raspberry ketone and similar products show little or no effect, and some have been linked to liver damage.
Information only. Not a recommendation or endorsement of any product. Whether a medicine suits you depends on your health and other medicines, so talk to your doctor or pharmacist. In an emergency, call 000 (Australia) or your local emergency number. From a mobile, 112 works in most countries.
More information
- SURMOUNT-1 trial: Tirzepatide for obesity (NEJM)
- SURMOUNT-4 trial: Continuing versus stopping tirzepatide (JAMA)
- STEP 1 trial: Semaglutide for weight management (NEJM)
- STEP 1 extension: Weight regain after stopping semaglutide
- SCALE trial: Liraglutide 3 mg for weight management
- Phentermine/topiramate: EQUIP and CONQUER results
- COR-I trial: Naltrexone/bupropion (The Lancet, 2010)
- XENDOS trial: Orlistat over 4 years
- Duromine (phentermine) product information
- Contrave product information
- Medsafe: Topiramate and pregnancy (2025)
- PBS: Wegovy listing status
- Healio: FDA approves Wegovy pill
- Pharmacy Times: FDA approves orforglipron (April 2026)
- Pharmacy Daily: Orforglipron submitted in Australia
- BioSpace: CagriSema filed with the FDA
- Pharmacy Times: Retatrutide TRIUMPH-1 results (May 2026)
- US National Institutes of Health: Dietary supplements for weight loss
- CBS News: FDA and FTC act on HCG weight-loss products
maladywise.com/medicines/weight-loss-medicines/